Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from pepsgpt.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| AOD-9604 | 2 | 99.65% |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| — |
| BPC-157 | 8 | 99.31% | — | — | — |
| BPC-157 + TB-500 | 2 | — | — | — | — | — | — |
| Cagrilintide | 2 | 99.28% | — | — | — |
| GHK-Cu | 4 | 99.48% | — | — | — |
| GLOW | 1 | — | — | — | — | — | — |
| Hexarelin | 2 | 99.19% | — | — | — |
| Ipamorelin | 3 | 99.27% | — | — | — |
| Ipamorelin + CJC-1295 | 1 | — | — | — | — | — | — |
| Kisspeptin-10 | 2 | 99.26% | — | — | — |
| KLOW | 1 | — | — | — | — | — | — |
| L-Glutathione | 2 | 99.41% | — | — | — |
| Melanotan 2 MT-2 | 2 | 99.15% | — | — | — |
| MOTS-c | 1 | 99.39% | — | — | — |
| NAD+ | 4 | 99.45% | — | — | — |
| Oxytocin | 2 | 99.41% | — | — | — |
| PT-141 | 2 | 99.25% | — | — | — |
| Retatrutide | 6 | 99.33% | — | — | — |
| Selank | 2 | 99.37% | — | — | — |
| Semaglutide | 2 | 99.23% | — | — | — |
| Semax | 2 | 99.18% | — | — | — |
| Sermorelin | 2 | 99.27% | — | — | — |
| TB-500 | 2 | 99.25% | — | — | — |
| Tesamorelin | 2 | 99.19% | — | — | — |
| Thymosin Alpha-1 | 2 | 99.32% | — | — | — |
| Tirzepatide | 6 | 99.33% | — | — | — |
| 2026-05-12 |
| View |
| Tirzepatide | P-9887337-P | Horizon Analytical | 99.29% | MS | 2026-05-12 | View |
| Tirzepatide | P-9887337-E | Horizon Analytical | — | LAL | 2026-05-12 | View |
| AOD-9604 | P-3713888-P | Horizon Analytical | 99.65% | MS | 2026-05-11 | View |
| AOD-9604 | P-3713888-E | Horizon Analytical | — | LAL | 2026-05-11 | View |
| BPC-157 + TB-500 | P-2917829-E | Horizon Analytical | — | LAL | 2026-05-10 | View |
| BPC-157 | P-2917829-P | Horizon Analytical | 99.26% | MS | 2026-05-10 | View |
| Tirzepatide | P-3795846-E | Horizon Analytical | — | LAL | 2026-05-09 | View |
| NAD+ | P-1630816-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| BPC-157 | P-3548854-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| BPC-157 | P-3548854-P | Horizon Analytical | 99.24% | MS | 2026-05-08 | View |
| GHK-Cu | P-5920245-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| Tirzepatide | P-3038615-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| NAD+ | P-7932744-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| NAD+ | P-7932744-P | Horizon Analytical | 99.39% | MS | 2026-05-08 | View |
| Thymosin Alpha-1 | P-1947064-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| Retatrutide | P-9490216-P | Horizon Analytical | 99.33% | MS | 2026-05-08 | View |
| Semax | P-1902514-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| Retatrutide | P-9490216-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| Kisspeptin-10 | P-8975198-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| L-Glutathione | P-3871218-P | Horizon Analytical | 99.41% | MS | 2026-05-08 | View |
| GHK-Cu | P-5920245-P | Horizon Analytical | 99.46% | MS | 2026-05-08 | View |
| Hexarelin | P-7132129-P | Horizon Analytical | 99.19% | MS | 2026-05-08 | View |
| Hexarelin | P-7132129-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| L-Glutathione | P-3871218-E | Horizon Analytical | — | LAL | 2026-05-08 | View |
| NAD+ | P-1630816-P | Horizon Analytical | 99.51% | MS | 2026-05-08 | View |
| Oxytocin | P-4275312-E | Horizon Analytical | — | LAL | 2026-05-06 | View |
| Oxytocin | P-4275312-P | Horizon Analytical | 99.41% | MS | 2026-05-06 | View |
| MOTS-c | P-4301315-P | Horizon Analytical | 99.39% | MS | 2026-05-05 | View |
| Selank | P-2406449-E | Horizon Analytical | — | LAL | 2026-05-04 | View |
| Ipamorelin + CJC-1295 | P-3437208-E | Horizon Analytical | — | LAL | 2026-05-04 | View |
| GHK-Cu | P-9250030-E | Horizon Analytical | — | LAL | 2026-05-04 | View |
| Ipamorelin | P-3437208-P | Horizon Analytical | 99.28% | MS | 2026-05-04 | View |
| GHK-Cu | P-9250030-P | Horizon Analytical | 99.51% | MS | 2026-05-04 | View |
| Tesamorelin | P-7980975-E | Horizon Analytical | — | LAL | 2026-05-03 | View |
| Semaglutide | P-2885342-P | Horizon Analytical | 99.23% | MS | 2026-05-03 | View |
| PT-141 | P-2061592-E | Horizon Analytical | — | LAL | 2026-05-03 | View |
| Tesamorelin | P-7980975-P | Horizon Analytical | 99.19% | MS | 2026-05-03 | View |
| Melanotan 2 MT-2 | P-7423137-P | Horizon Analytical | 99.15% | MS | 2026-05-03 | View |
| Melanotan 2 (MT-2) | P-7423137-E | Horizon Analytical | — | LAL | 2026-05-03 | View |
| PT-141 | P-2061592-P | Horizon Analytical | 99.25% | MS | 2026-05-03 | View |
| Semax | P-1902514-P | Horizon Analytical | 99.18% | MS | 2026-05-01 | View |
| Kisspeptin-10 | P-8975198-P | Horizon Analytical | 99.26% | MS | 2026-04-30 | View |
| BPC-157 | P-4900644-E | Horizon Analytical | — | LAL | 2026-04-30 | View |
| BPC-157 | P-4900644-P | Horizon Analytical | 99.39% | MS | 2026-04-30 | View |
| Selank | P-2406449-P | Horizon Analytical | 99.37% | MS | 2026-04-26 | View |
| Semaglutide | P-2885342-E | Horizon Analytical | — | LAL | 2026-04-26 | View |
| Thymosin Alpha-1 | P-1947064-P | Horizon Analytical | 99.32% | MS | 2026-04-26 | View |
Disclosed Labs